<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>OPERATOR_BCSC1819_S12_C17_p331-350_3P</title>
		<link href="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="OPERATOR_BCSC1819_S12_C17_p331-350_3P" lang="en-US">
		<div id="_idContainer010" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter</span><span class="cn-chap"> </span>17</p>
			<p class="chapter-title">Diseases of the Vitreous and Vitreoretinal Interface</p>
			<p class="video-list-mid ParaOverride-1"><img class="_idGenObjectAttribute-1" src="data:image/png;base64,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" alt="" />&#9;<span class="italic">This chapter includes related activities, which can be accessed by scanning the QR codes provided</span><span class="italic"> in the text or &#173;going to </span><a href="http://www.aao.org/bcscactivity_section12"><span class="italic">www.&#173;aao.&#173;org/&#173;bcscactivity_&#173;section12</span></a><span class="italic">.</span></p>
			<p class="h1">Posterior Vitreous Detachment</p>
			<div id="Chapt17_Top1">
			<p class="body-text--no-indent-">The vitreous is a transparent connective tissue composed of collagen and hyaluronan that is attached to the basal lamina of the lens, optic nerve, and ret&#173;ina, and fills the posterior chamber of the eye. A posterior vitreous detachment (PVD) is the separation of the posterior cortical gel from the ret&#173;i&#173;nal surface, including its adhesions at the optic nerve head (the area of Martegiani), the macula, and blood vessels. At its base, the vitreous remains firmly attached to the retina—&#173;even &#173;after severe trauma—&#173;sometimes resulting in vitreous base avulsion. &#173;Because of this firm attachment, the basal cortical vitreous collagen cannot be peeled off the ret&#173;i&#173;na; instead, the vitreous must be “shaved” during vitrectomy, instead of being removed. See <span class="xref-local">Chapter&#160;16</span>&#160;in this volume for more on PVD.</p>
			<p class="body-text">With advancing age, the vitreous gel undergoes both liquefaction (synchysis) and collapse (syneresis). The viscous hyaluronan accumulates in lacunae, which are surrounded by displaced collagen fibers. The gel can then contract, possibly &#173;because of electrostatic attraction and crosslinking of adjacent collagen fibers in the absence of hyaluronan. With this contraction, the posterior cortical gel detaches &#173;toward the firmly attached vitreous base. The prevalence of PVD is increased in patients who have had cataract extractions, particularly if the posterior capsule’s integrity has been &#173;violated. Prevalence is also increased in individuals with a history of vitritis &#173;because of the loss or alteration of hyaluronan. Localized regions of the posterior cortical gel can separate slowly, over the course of many years, with few if any symptoms, compared with the more acute, symptomatic event.</p>
			<p class="body-text">The diagnosis of PVD is often made with indirect ophthalmoscopy or slit-&#173;lamp biomicroscopy, with which the posterior vitreous face may be observed a few millimeters in front of the ret&#173;i&#173;nal surface. In eyes with a PVD, a translucent ring of fibroglial tissue (the “Weiss” or “Vogt” ring) is frequently torn loose from the surface of the optic nerve head, and its observation helps the clinician make the diagnosis. Although a shallow detachment of the posterior cortical gel may be difficult or impossible to observe with biomicroscopy, this type of detachment may be revealed on contact B-&#173;scan ultrasonography as a thin, hyperreflective line bounding the posterior vitreous. Optical coherence tomography (OCT) has shown that PVDs often start as a localized detachment of the vitreous over the perifovea, called a <span class="italic">posterior perifoveal vitreous detachment,</span> &#173;later spreading anteriorly to involve larger areas.</p>
			<p class="body-text">Per&#173;sis&#173;tent focal attachment of the vitreous to the ret&#173;ina can cause a number of pathologic conditions. Vitreous contraction as well as traction caused by ocular saccades may lead to breaks, particularly at the posterior edge of the vitreous base. Per&#173;sis&#173;tent attachment to the macula may lead to vitreomacular traction syndrome. Focal attachment to the foveola can induce foveal cavitation and macular hole formation (<span class="xref-figure">Fig 17-1</span>). Remnants of the vitreous often remain on the internal limiting membrane (ILM) &#173;after a posterior vitreous “detachment.” For this reason, some authorities state that a presumed PVD often is actually posterior vitreoschisis that is internal or external to the layer of hyalocytes. &#173;These vitreous remnants may have a role in epiret&#173;i&#173;nal membrane or macular hole formation and can contribute to tractional detachments in patients with pathologic myopia and to macular edema in patients with diabetes mellitus. Plaques of &#173;these adherent remnants of cortical vitreous can often be highlighted during vitreous surgery by applying triamcinolone (<span class="xref-figure">Fig 17-2</span>).</p>
			<p class="reference--journal--first">Gupta P, Yee KM, Garcia P, et&#160;al. Vitreoschisis in macular diseases. <span class="italic">Br J Ophthalmol.</span> 2011;95(3):376–380.</p>
			<p class="reference--journal--mid">Sakamoto T, Ishibashi&#160;T. Hyalocytes: essential cells of the vitreous cavity in vitreoret&#173;i&#173;nal pathophysiology? <span class="italic">Ret&#173;i&#173;na.</span> 2011;31(2):222–228.</p>
			<p class="h2">Epiretinal Membranes</p>
			<p class="body-text--no-indent-">An epiret&#173;i&#173;nal membrane (ERM) is a transparent, avascular, fibrocellular membrane on the inner ret&#173;i&#173;nal surface that adheres to and covers the ILM of the ret&#173;ina. Proliferation of glia, ret&#173;i&#173;nal pigment epithelium (RPE), or hyalocytes at the vitreoret&#173;i&#173;nal interface, especially at the posterior pole, results in ERM formation.</p>
			<p class="body-text">ERMs are relatively common; at autopsy, they are discovered in 2% of patients older than 50&#160;years and in 20% older than 75&#160;years. ERMs are most common in persons over age 50&#160;years, and both sexes are equally affected. The incidence of bilaterality is approximately 10%–20%, and severity is usually asymmetric. Detachment or separation of the posterior vitreous is pres&#173;ent in almost all eyes with idiopathic epiret&#173;i&#173;nal membranes, and may be a requisite for ERM development. Schisis of the posterior vitreous may leave variable portions of the posterior cortical vitreous attached to the macula, allowing glial cells from the ret&#173;ina to proliferate along the ret&#173;i&#173;nal surface and hyalocytes to proliferate on posterior cortical vitreous remnants on the ret&#173;i&#173;nal surface. Secondary ERMs occur regardless of age or sex in association with abnormal vitreoret&#173;i&#173;nal adhesions and areas of inflammation, as well as following ret&#173;i&#173;nal detachment or ret&#173;i&#173;nal bleeding.</p>
			<p class="h3">Signs and symptoms</p>
			<p class="body-text--no-indent-">Epiret&#173;i&#173;nal proliferation is generally located in the central macula—&#173;over, surrounding, or eccentric to the fovea (<span class="xref-figure">Fig 17-3</span>). The membranes usually appear as a mild sheen or glint on the ret&#173;i&#173;nal surface. Over time, ERMs become more extensive, increasing ret&#173;i&#173;nal distortion and thickening (Figs 17-4 and 17-5; <span class="xref-figure">Activities 17-1</span> and <span class="xref-figure">17-2</span>). However, their rate of progression and severity vary greatly. In some cases, the ERM may become opaque, obscuring under&#173;lying ret&#173;i&#173;nal details. A “pseudohole” appearance is produced when this preret&#173;i&#173;nal membrane contracts to the edge of the clivus, steepening the gentle slope around the fovea into a cylindrical depression. Occasionally, intraret&#173;i&#173;nal hemorrhages or whitened patches of superficial ret&#173;ina representing delayed axoplasmic flow in the nerve fiber layer (NFL) and edema may be pres&#173;ent. The cellular origin of ERMs is still &#173;under debate. Histologic examination reveals mainly RPE cells and ret&#173;i&#173;nal glial cells (astrocytes and M<span class="accent">ü</span>ller cells); however, myofibroblasts, fibroblasts, hyalocytes, and macrophages have also been identified.</p>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="data:image/jpg;base64,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" alt="" />
				</div>
			</div>
			<p class="QR-code-caption-first-recto ParaOverride-2"> <span class="QR-code-activity-number">ACTIVITY 17-1</span> OCT Activity: Epiret&#173;i&#173;nal membrane.</p>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer003" class="_idGenObjectStyleOverride-1">
					<div id="_idContainer002" class="_idGenObjectStyleOverride-1">
						<img class="_idGenObjectAttribute-2" src="data:image/png;base64,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" alt="" />
					</div>
				</div>
			</div>
			<p class="QR-code-source-recto ParaOverride-2"><span class="QR-code-source-italic">Courtesy of Colin&#160;A. McCannel, MD.</span></p>
			<p class="QR-code-text-last-recto ParaOverride-2">Access all Section&#160;12 activities at <a href="http://www.aao.org/bcscactivity_section12">www.&#173;aao.&#173;org/&#173;bcscactivity_&#173;section12</a>.</p>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer004" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="data:image/jpg;base64,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" alt="" />
				</div>
			</div>
			<p class="QR-code-caption-first-recto ParaOverride-2"> <span class="QR-code-activity-number">ACTIVITY 17-2</span> OCT Activity: Epiret&#173;i&#173;nal membrane progression.</p>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer006" class="_idGenObjectStyleOverride-1">
					<div id="_idContainer005" class="_idGenObjectStyleOverride-1">
						<img class="_idGenObjectAttribute-2" src="data:image/png;base64,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" alt="" />
					</div>
				</div>
			</div>
			<p class="QR-code-source-recto ParaOverride-3"><span class="QR-code-source-italic">Courtesy of Colin&#160;A. McCannel, MD.</span></p>
			<p class="body-text">Contracture of ERMs produces distortion and wrinkling of the inner surface of the ret&#173;ina, called <span class="italic">cellophane maculopathy</span> or <span class="italic">preret&#173;i&#173;nal macular fibrosis.</span> It can range from mild to severe, with w<span class="italic">rinkling</span> or <span class="italic">striae</span> to severe <span class="italic">macular puckering</span>. Increased traction may cause shallow macular detachment, diffuse thickening, or cystic changes. Furthermore, traction on ret&#173;i&#173;nal vessels results in increased vascular tortuosity and straightening of the perimacular vessels. Fluorescein angiography (FA) may show staining of the optic nerve and capillary leakage in the central macula. The most common OCT findings are a highly reflective epiret&#173;i&#173;nal reflective layer, loss of the normal ret&#173;i&#173;nal contour, and ret&#173;i&#173;nal thickening. Additional findings include irregularities of the inner ret&#173;i&#173;nal surface and cystic edema.</p>
			<p class="h3 ParaOverride-4">Treatment</p>
			<p class="body-text--no-indent-">When ERMs are asymptomatic and visual acuity is good, intervention is not indicated. Asymptomatic ERMs should be monitored periodically, &#173;because they &#173;will often worsen, sometimes over a relatively short period of time, &#173;after being stable. In rare cases, an ERM may spontaneously detach from the inner ret&#173;i&#173;nal surface, with concomitant improvement or resolution of the ret&#173;i&#173;nal distortion and improvement in symptoms and vision. If the patient is bothered by reduced visual acuity or metamorphopsia, vitrectomy should be considered (see also <span class="xref-local">Chapter&#160;20</span>). The goal of surgery is to optimize visual acuity, reduce metamorphopsia, and restore binocularity if it was affected preoperatively.</p>
			<p class="reference--journal--single ParaOverride-5">Johnson TM, Johnson MW. Epiret&#173;i&#173;nal membrane. In: Yanoff M, Duker JS. <span class="italic">Ophthalmology.</span> 4th&#160;ed. St Louis: Elsevier; 2014:614–619.</p>
			<p class="h2 ParaOverride-6">Vitreomacular Traction Diseases</p>
			<p class="body-text--no-indent-">Vitreomacular traction diseases include abnormalities that arise from focal or broad vitreomacular adhesions in the presence of detaching or other&#173;wise detached posterior vitreous. The 3 recognized categories of vitreomacular traction disease are: (1) vitreomacular adhesion (VMA), (2) vitreomacular traction (VMT) syndrome, and (3) macular hole. <span class="xref-table">&#173;Table&#160;17-1</span> summarizes a useful classification system for &#173;these categories that relies on OCT findings.</p>
			<p class="h3 ParaOverride-4">Vitreomacular adhesions</p>
			<p class="body-text--no-indent-">VMAs typically do not cause visual symptoms. They can be focal or diffuse and can lead to secondary traction disease, that is, VMT and macular hole.</p>
			<p class="h3 ParaOverride-4">Vitreomacular traction syndrome</p>
			<p class="body-text--no-indent-">In VMT syndrome, the posterior hyaloid is abnormally adherent to the macula (eg, a VMA). As the vitreous detaches, the posterior hyaloid remains tethered at the macula, usually the fovea, causing tractional foveal distortion, cystic edema, and, in severe cases, tractional foveal detachment. &#173;These changes lead to decreased visual acuity, metamorphopsia, and often vague reports about poor vision in the affected eye that are out of proportion to the mea&#173;sured visual acuity. Angiography may demonstrate leakage of fluorescein dye from macular vessels as well as from the optic nerve. OCT is useful to demonstrate the vitreoret&#173;i&#173;nal interface abnormalities and the tractional effects of VMT syndrome on the foveal architecture. Chronic traction is generally understood to be harmful over the long term, particularly when cystic edema is pres&#173;ent or when the patient’s vision is affected. Spontaneous separation of the focal vitreoret&#173;i&#173;nal adhesion, with resolution of all clinical features, occurs in approximately 50% of cases, and less commonly when &#173;there is an associated ERM or the adhesion is broad (<span class="xref-figure">Fig 17-6</span>).</p>
			<p class="body-text">Intervention should be considered for VMT syndrome; it includes pars plana vitrectomy with membrane peeling or intravitreal injection of ocriplasmin. Vitrectomy surgery is highly successful in achieving resolution of VMT (see also <span class="xref-local">Chapter&#160;20</span>).</p>
			<p class="body-text">Ocriplasmin is a recombinant protease with activity against fibronectin and laminin; it has a variable success rate. A multicenter clinical trial found that resolution of vitreomacular traction occurred in 26.5% of ocriplasmin-&#173;injected eyes compared with 10.1% of placebo-&#173;injected eyes over the same period. In a subset of patients with vitreomacular adhesions smaller than 1500 µm, the rate of resolution increased to 33.6%. Unfortunately, a small number of patients experienced permanent visual loss with electroretinogram (ERG) changes. This may be due to a disruption of the interphotoreceptor matrix, leading to ellipsoid layer attenuation.</p>
			<p class="reference--journal--single">Margo JA, Shocket LS, Kilma K, Johnson MA. Per&#173;sis&#173;tent ret&#173;i&#173;nal changes &#173;after intravitreal ocriplasmin. <span class="italic">Retin Cases Brief Rep.</span> 2016;10(1):48–51.</p>
			<p class="h2">Idiopathic Macular Holes</p>
			<p class="body-text--no-indent-">Idiopathic macular holes occur at a rate of approximately 8 per 100,000 persons per year and have a female-&#173;to-&#173;male ratio of 2 to 1. They occur mostly in the sixth through eighth de&#173;cades of life and can appear at a younger age in myopic eyes. Idiopathic macular holes are bilateral in approximately 10% of patients. Investigations using OCT suggest that idiopathic macular holes are caused by the same tractional forces as the forces associated with perifoveal vitreous detachment and thus are likely an early stage of age-&#173;related PVD.</p>
			<p class="body-text">The following description of the stages of macular hole formation is useful in making management decisions (<span class="xref-figure">Fig 17-7</span>):</p>
			<ul>
				<li class="bullet-list-first ParaOverride-7">A stage 0, or premacular, hole occurs when a PVD with per&#173;sis&#173;tent foveal attachment develops. Subtle loss of the foveal depression can be observed, and visual acuity is usually unaffected. Most stage 0 holes do not pro&#173;gress to advanced stages. This stage represents a VMA.</li>
				<li class="bullet-list-mid ParaOverride-7">A stage 1 macular hole (impending macular hole) typically &#173;causes visual symptoms of metamorphopsia and central vision decline, usually to a visual acuity range of 20/25 to 20/60. The characteristic findings are &#173;either a small yellow spot (stage 1A) or a yellow circle (stage 1B) in the fovea. OCT examination reveals that a stage 1A hole is a foveal “pseudocyst,” or horizontal splitting (schisis), associated with vitreous traction to the foveal center. A stage 1B hole indicates a break in the outer fovea, the margins of which constitute the yellow ring noted clinically. Spontaneous resolution of a stage 1 hole occurs in approximately 50% of cases without ERM. This stage represents VMT syndrome.</li>
				<li class="bullet-list-mid ParaOverride-7">A stage 2 macular hole represents an early full-&#173;thickness macular hole that is less than 400 µm in dia&#173;meter. It results from the progression of a foveal schisis (pseudocyst) to a full-&#173;thickness dehiscence, as a tractional break develops in the “roof” (inner layer) of the pseudocyst. Progression to stage 2 is accompanied by a further decline in visual acuity. OCT demonstrates the full-&#173;thickness defect and the continuing attachment of the posterior hyaloid to the foveal center. This stage represents VMT syndrome with a small-&#173; to medium-&#173;sized macular hole.</li>
				<li class="bullet-list-mid ParaOverride-7">A stage 3 macular hole is a fully developed hole (<span class="symbol">≥</span>400 µm in dia&#173;meter), typically surrounded by a rim of thickened and detached ret&#173;ina. Visual acuity ranges widely. The posterior hyaloid remains attached to the optic nerve head but is detached from the fovea. An operculum suspended by the posterior hyaloid may be seen overlying the hole. On OCT, this stage represents a large macular hole with no VMT (<span class="xref-figure">Activity 17-3</span>, <span class="xref-figure">Fig 17-8</span>).</li>
				<li class="bullet-list-last ParaOverride-7">A stage 4 macular hole is a fully developed hole with a complete posterior vitreous detachment, as evidenced by the presence of a Weiss ring. On OCT, this stage represents a large macular hole with no VMT.<div id="_idContainer007" class="_idGenObjectStyleOverride-1"><img class="_idGenObjectAttribute-2" src="data:image/jpg;base64,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" alt="" /></div><p class="QR-code-caption-first-recto ParaOverride-8"> <span class="QR-code-activity-number">ACTIVITY 17-3</span> OCT Activity: Macular hole.</p><div id="_idContainer009" class="_idGenObjectStyleOverride-1"><div id="_idContainer008" class="_idGenObjectStyleOverride-1"><img class="_idGenObjectAttribute-2" src="data:image/png;base64,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" alt="" /></div></div></li>
			</ul>
			<p class="QR-code-source-recto ParaOverride-2"><span class="QR-code-source-italic">Courtesy of Colin&#160;A. McCannel, MD.</span></p>
			<p class="body-text">The fellow-&#173;eye risk of macular hole development depends on the vitreous attachment status. If a complete vitreous detachment is pres&#173;ent in the fellow eye, &#173;there is &#173;little, if any, risk of macular hole development. If the fellow eye has stage 1A abnormalities, however, &#173;there is a substantial risk of progression to a full-&#173;thickness macular hole. When the fellow eye is normal and its vitreous is attached, the risk of developing a macular hole in that eye is approximately 10%, the rate of bilaterality.</p>
			<p class="h3">Management options</p>
			<p class="body-text--no-indent-">For stage 2 or greater macular holes, surgical intervention is recommended—&#173;specifically, pars plana vitrectomy with gas tamponade; in most recent case series, the success rate of this procedure for closure and vision improvement was greater than 90% (see &#173;<span class="xref-local">Chapter&#160;20&#160;in this volume</span>). Modifications of routine macular hole surgery are usually reserved for very large, chronic, or nonclosing holes; &#173;these include inverted ILM flaps and autologous ret&#173;i&#173;nal grafts composed of peripheral ret&#173;ina. Although &#173;these techniques may achieve anatomical hole closure, visual acuity may not improve.</p>
			<p class="body-text">Stage 1 macular holes have an approximate 50% rate of spontaneous resolution and thus are typically monitored. An alternative management option for stage 1 holes or holes that are less than 250 µm in dia&#173;meter is the intravitreal injection of ocriplasmin. In the ocriplasmin phase 3 clinical trial, the closure rate of full-&#173;thickness macular holes was 40.6% overall and 58.3% for holes of less than 250 µm dia&#173;meter. Ocriplasmin is most effective in eyes with focal adhesions and much less effective for broad vitreoret&#173;i&#173;nal adhesions or adhesions associated with an ERM.</p>
			<p class="reference--journal--first">Duker JS, Kaiser PK, &#173;Binder S, et&#160;al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. <span class="italic">Ophthalmology.</span> 2013;120(12):2611–2619.</p>
			</div>
			<p class="h1">Developmental Abnormalities</p>
			<div id="Chapt17_Top2">
			<p class="h2-h1">Tunica Vasculosa Lentis</p>
			<p class="body-text--no-indent-">Although they are commonly observed, remnants of the tunica vasculosa lentis and hyaloid artery are not visually significant. Mittendorf dot, an anterior remnant, is a small, dense, and white round plaque attached to the posterior lens capsule nasally and inferiorly to its posterior pole. A prepapillary remnant known as Bergmeister papilla is a fibroglial tuft of tissue extending into the vitreous for a short distance at the margin of the optic nerve head. The entire hyaloid artery may persist from optic nerve head to lens as multilayered fenestrated sheaths forming the Cloquet canal.</p>
			<p class="h2">Prepapillary Vascular Loops</p>
			<p class="body-text--no-indent-">Initially thought to be remnants of the hyaloid artery, prepapillary vascular loops are normal ret&#173;i&#173;nal vessels that have grown into Bergmeister papilla before returning to the ret&#173;ina (<span class="xref-figure">Fig 17-9</span>). The loops typically extend less than 5&#160;mm into the vitreous. &#173;These vessels may supply one or more quadrants of the ret&#173;ina. FA has shown that 95% of &#173;these vessels are arterial and 5% are venous. Complications associated with &#173;these vessels include branch ret&#173;i&#173;nal artery obstruction, amaurosis fugax, and vitreous hemorrhage.</p>
			<p class="h2">Per&#173;sis&#173;tent Fetal Vasculature</p>
			<p class="body-text--no-indent-">Per&#173;sis&#173;tent fetal vasculature (PFV), previously known as <span class="italic">per&#173;sis&#173;tent hyperplastic primary vitreous,</span> is a congenital anomaly thought to result from failure of the primary vascular vitreous to regress. The disorder is unilateral in 90% of cases and usually has no associated systemic findings. Anterior, posterior, and combined forms of this developmental abnormality have been described. Most cases are sporadic, but PFV can occur as &#173;either an autosomal recessive (mutations in the <span class="italic">ATOH7</span> gene) or autosomal dominant trait. In some patients with mutations, the disease can be asymmetric and bilateral, with the fellow eye showing variable changes, including  avascularity. See BCSC Section&#160;6, <span class="italic">Pediatric Ophthalmology and Strabismus,</span> for more on PFV.</p>
			<p class="h3">Anterior per&#173;sis&#173;tent fetal vasculature</p>
			<p class="body-text--no-indent-">In anterior PFV, the hyaloid artery remains, and a white vascularized fibrous membrane or mass is pres&#173;ent &#173;behind the lens. Associated findings include microphthalmos, a shallow anterior chamber, and elongated ciliary pro&#173;cesses that are vis&#173;i&#173;ble around the small lens. Leukocoria is often pres&#173;ent at birth. A dehiscence of the posterior lens capsule may, in many cases, cause swelling of the lens and cataract as well as secondary angle-&#173;closure glaucoma. In addition, glaucoma may result from incomplete development of the chamber &#173;angle.</p>
			<p class="body-text">The natu&#173;ral course of anterior PFV may result in blindness in the most advanced cases. Lensectomy and removal of the fibrovascular retrolental membrane prevent angle-&#173;closure glaucoma in some cases; however, growth of a secondary cataract is common. Deprivational and refractive amblyopia is a serious postoperative challenge in &#173;these patients.</p>
			<p class="body-text">Anterior PFV should be considered in the differential diagnosis of leukocoria. Differentiating it from retinoblastoma is particularly impor&#173;tant. Unlike PFV, retinoblastoma is usually not obvious at birth, is more often bilateral, and is almost never associated with microphthalmos or cataract. PFV is anterior in the eye at birth; retinoblastomas do not appear in the anterior fundus &#173;until well &#173;after birth. Ancillary testing, such as diagnostic echography and x-&#173;ray techniques to look for calcification within the retinoblastoma, can be helpful in differentiating the 2 disorders.</p>
			<p class="h3 ParaOverride-10">Posterior per&#173;sis&#173;tent fetal vasculature</p>
			<p class="body-text--no-indent-">Posterior PFV may occur in association with anterior PFV or as an isolated finding. The eye may be microphthalmic, but the anterior chamber is usually normal and the lens is typically clear and without a retrolental membrane. A stalk of tissue emanates from the optic nerve head and courses &#173;toward the retrolental region, often &#173;running along the apex of a ret&#173;i&#173;nal fold that may extend anteriorly from the optic nerve head, usually in an inferior quadrant. The stalk fans out circumferentially &#173;toward the anterior ret&#173;ina. Posterior PFV should be differentiated from retinopathy of prematurity (ROP), familial exudative vitreoretinopathy, and ocular toxocariasis. Surgical repair of posterior PFV consists of lensectomy and vitrectomy, which result in formed vision in about 70% of cases.</p>
			<p class="reference--journal--first">Goldberg MF. Per&#173;sis&#173;tent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with per&#173;sis&#173;tent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. <span class="italic">Am J Ophthalmol.</span> 1997;124(5):587–626.</p>
			<p class="reference--journal--mid">Sisk RA, Berrocal AM, Feuer WJ, Murray TG. Visual and anatomic outcomes with or without surgery in per&#173;sis&#173;tent fetal vasculature. <span class="italic">Ophthalmology.</span> 2010;117(11):2178–2183.</p>
			</div>
			<p class="h1 ParaOverride-11">Hereditary Hyaloideoretinopathies With Optically Empty <br />Vitreous: Wagner and Stickler Syndromes</p>
			<div id="Chapt17_Top3">
			<p class="body-text--no-indent-">The hallmark of the group of conditions known as hereditary hyaloideoretinopathies is vitreous liquefaction (synchysis) that results in an optically empty cavity except for a thin layer of cortical vitreous &#173;behind the lens and threadlike, avascular membranes that run circumferentially and adhere to the ret&#173;ina. Fundus abnormalities include equatorial and perivascular (radial) lattice degeneration. The ERG response may be subnormal.</p>
			<p class="body-text">In Wagner disease, the optically empty vitreous is accompanied by myopia, strabismus, and cataract, but &#173;there are no associated systemic findings. It is not associated with ret&#173;i&#173;nal detachment and has an autosomal dominant inheritance pattern.</p>
			<p class="body-text">Stickler syndrome is the most common variety of hereditary hyaloideoretinopathy with associated systemic findings (<span class="xref-figure">Fig 17-10</span>) and is transmitted as an autosomal dominant trait. Most patients have a mutation in the gene <span class="italic">COL2A1,</span> which encodes type II procollagen. Vari&#173;ous mutations may produce Stickler syndrome phenotypes of differing severity. Additional ocular abnormalities include myopia, open-&#173;angle glaucoma, and cataract. Orofacial findings include midfacial flattening and the Pierre Robin malformation complex of cleft palate, micrognathia, and glossoptosis. &#173;These abnormalities may be dramatic at birth, requiring tracheostomy, or they may not be obvious at all. Generalized skeletal abnormalities include joint hyperextensibility and enlargement; arthritis, particularly of the knees; and mild spondyloepiphyseal dysplasia. Early recognition of this syndrome is very impor&#173;tant &#173;because of the high incidence of ret&#173;i&#173;nal detachment. In one case series, ret&#173;i&#173;nal tears &#173;were associated with mutations in <span class="italic">COL2A1</span> in 91% of cases and ret&#173;i&#173;nal detachments in 53%. The detachments may be difficult to repair &#173;because of multiple, posterior, or large breaks and a tendency &#173;toward proliferative vitreoretinopathy. Patients with this condition typically have cortical vitreous condensations that are firmly adherent to the ret&#173;ina. For this reason, prophylactic treatment of ret&#173;i&#173;nal breaks should be considered. (See the section Prophylactic Treatment of Ret&#173;i&#173;nal Breaks in <span class="xref-local">Chapter&#160;16</span>.)</p>
			<p class="body-text">Other forms of hereditary hyaloideoretinopathy associated with systemic abnormalities include Weill-&#173;Marchesani syndrome and some va&#173;ri&#173;e&#173;ties of dwarfism.</p>
			<p class="reference--journal--first">Maumenee IH. Vitreoret&#173;i&#173;nal degeneration as a sign of generalized connective tissue diseases. <span class="italic">Am J Ophthalmol.</span> 1979;88(3 Pt 1):432–449.</p>
			<p class="reference--journal--mid">Rose PS, Levy HP, Liberfarb RM, et&#160;al. Stickler syndrome: clinical characteristics and diagnostic criteria. <span class="italic">Am J Med Genet&#160;A.</span> 2005;138A(3):199–207.</p>
			</div>
			<p class="h1">Familial Exudative Vitreoretinopathy</p>
			<div id="Chapt17_Top4">
			<p class="body-text--no-indent-">Familial exudative vitreoretinopathy (FEVR) is characterized by failure of the temporal ret&#173;ina to vascularize and is phenotypically similar to ROP. Ret&#173;i&#173;nal folds and peripheral fibrovascular proliferation as well as tractional and exudative ret&#173;i&#173;nal detachment are often associated with FEVR (<span class="xref-figure">Fig 17-11</span>). Temporal dragging of the macula may cause the patient to appear to have exotropia. Late-&#173;onset rhegmatogenous ret&#173;i&#173;nal detachments may occur. Generally, the earlier the disease pres&#173;ents, the more severe the manifestations.</p>
			<p class="body-text">The condition is frequently bilateral, although the severity of ocular involvement may be asymmetric. Unlike patients with ROP, individuals with FEVR are born full term and have normal respiratory status. In FEVR, the peripheral ret&#173;i&#173;nal vessels are dragged, straightened, and end abruptly a variable distance from the ora (brush border). Differentiation of FEVR from ROP is also aided by the &#173;family history and a careful examination of all &#173;family members. The only finding in some &#173;family members with FEVR may be a straightening of vessels and peripheral ret&#173;i&#173;nal nonperfusion. Parents and siblings of affected &#173;children may be mildly affected and asymptomatic. FA with peripheral sweeps or wide-&#173;field angiography is indispensable in examining &#173;family members. Treatment of the affected &#173;family members may consist of &#173;laser therapy applied to the avascular ret&#173;ina, guided by FA.</p>
			<p class="body-text">FEVR is usually inherited as an autosomal dominant trait, but X-&#173;linked transmission also occurs. Several dif&#173;fer&#173;ent gene loci have been associated with the FEVR phenotype (<span class="xref-table">&#173;Table&#160;17-2</span>). A number of ge&#173;ne&#173;tic disorders can pres&#173;ent with the ret&#173;i&#173;nal characteristics of FEVR, including dyskeratosis congenita, Coats plus disease, facioscapulohumeral muscular dystrophy, and progressive hemifacial atrophy (Parry-&#173;Romberg syndrome). It is impor&#173;tant to differentiate &#173;these diseases genet&#173;ically.</p>
			<p class="reference--journal--single">Ranchod TM, Ho LY, Drenser KA, Capone A Jr, Trese MT. Clinical pre&#173;sen&#173;ta&#173;tion of familial exudative vitreoretinopathy. <span class="italic">Ophthalmology.</span> 2011;118(10):2070–2075.</p>
			</div>
			<p class="h1">Vitreous Opacities</p>
			<div id="Chapt17_Top5">
			<p class="h2-h1">Vitreous Degeneration and Detachment Associated Opacities (“Floaters”)</p>
			<p class="body-text--no-indent-">Synchysis and syneresis result in loss of the highly or&#173;ga&#173;nized vitreous anatomy. The collagen fibers that make up the vitreous can coalesce, or tangle, producing small areas that are no longer transparent and can cast shadows. &#173;These shadows are perceived by patients as floaters, and patients may find them bothersome. In some cases, for example as in cases of myopic vitreopathy, a large, dense central opacity can form, obstructing vision.</p>
			<p class="body-text">Following vitreous detachment, the coalescence and tangling of vitreous collagen fibers can worsen. In addition, areas where the vitreous was attached more firmly, such as at the optic nerve, are less transparent. When &#173;these areas move away from the ret&#173;i&#173;nal surface, they too can cast shadows and may be perceived as floaters. Varying amounts of bleeding can occur at the time of vitreous detachment, producing vitreous opacities.</p>
			<p class="body-text">Over time, as the vitreous continues to liquefy, the vitreous opacities may sink &#173;toward the bottom and become less noticeable. Also, the brain has the capacity to learn to selectively ignore the floaters, an adaptation not unlike how &#173;people who live next to a train track eventually do not hear trains passing &#173;unless they are specifically paying attention. As a result, most patients become asymptomatic or minimally symptomatic and do not require any intervention.</p>
			<p class="h2">Asteroid Hyalosis</p>
			<p class="body-text--no-indent-">In asteroid hyalosis, minute white opacities composed of calcium-&#173;containing phospholipids are found in the other&#173;wise normal vitreous (<span class="xref-figure">Fig 17-12</span>). Clinical studies have confirmed a relationship between asteroid hyalosis and both diabetes mellitus and hypertension. Asteroid hyalosis has an overall incidence of 1&#160;in 200 persons, most frequently in &#173;people older than 50&#160;years. The condition is unilateral in 75% of cases, and significant decreases in visual acuity are rare. When PVD occurs, compression of the material occurs and visual acuity may decrease. When asteroid hyalosis blocks the view of the posterior fundus and ret&#173;i&#173;nal pathology is suspected, FA is usually successful in imaging the abnormalities. Occasionally, vitrectomy may be necessary to remove visually significant opacities or to facilitate treatment of under&#173;lying ret&#173;i&#173;nal abnormalities such as proliferative retinopathy. Many eyes with asteroid hyalosis have an abnormal vitreoret&#173;i&#173;nal interface with unusual vitreoret&#173;i&#173;nal adhesions. &#173;These adhesions increase the risk of ret&#173;i&#173;nal break formation during vitrectomy surgery.</p>
			<p class="reference--journal--single">Mochizuki Y, Hata Y, Kita T, et&#160;al. Anatomical findings of vitreoret&#173;i&#173;nal interface in eyes with asteroid hyalosis. <span class="italic">Graefes Arch Clin Exp Ophthalmol.</span> 2009;247(9):1173–1177.</p>
			<p class="h2">Vitreous Hemorrhage</p>
			<p class="body-text--no-indent-">A common cause of emergency visits to ophthalmology offices is sudden vision loss due to vitreous hemorrhage not associated with trauma to the eye. In adults, the most common &#173;causes include proliferative diabetic retinopathy (see <span class="xref-local">Chapter&#160;5</span>), PVD, central ret&#173;i&#173;nal vein occlusion, and ret&#173;i&#173;nal neovascularization from a variety of &#173;causes (see <span class="xref-table-local">Chapter&#160;7, &#173;Table&#160;7-2</span>). Bleeding can be exacerbated by the use of systemic anticoagulants, so physicians need to be aware of the systemic medi&#173;cations the patient is taking. In cases of vitreous hemorrhage associated with an acute PVD, ret&#173;i&#173;nal tears are found in approximately 50%–70% of eyes and clinical ret&#173;i&#173;nal detachment in 8%–12%. In &#173;children, X-&#173;linked hereditary retinoschisis and pars planitis are common &#173;causes of vitreous hemorrhage; however, trauma must always be considered in the differential diagnosis (see <span class="xref-local">Chapter&#160;18</span>).</p>
			<p class="body-text">In most cases of vitreous hemorrhage, the under&#173;lying cause can be determined by obtaining a history or on ret&#173;i&#173;nal examination. If the hemorrhage is too dense to permit indirect ophthalmoscopy or biomicroscopy, suggestive clues can be obtained from examination of the fellow eye. Diagnostic echography should be performed to detect any tractional tear (often superotemporally) and to rule out ret&#173;i&#173;nal detachment or tumor. Bilateral eye patching with bed rest for a few hours to several days, with the head of the bed elevated, may permit the intrahyaloid and retrohyaloid blood to &#173;settle, allowing for a better view of the posterior segment. If the etiology still cannot be established, the ophthalmologist should consider frequent reexamination with repeat echography &#173;until the cause is found. Alternatively, prompt diagnostic vitrectomy in nondiabetic patients can be considered and may help prevent progression of a ret&#173;i&#173;nal tear to ret&#173;i&#173;nal detachment. Ghost cell glaucoma can result from long-&#173;standing vitreous hemorrhage. Early intervention should be considered in monocular patients with vitreous hemorrhage. In addition, surgical intervention should be considered in patients whose hemorrhage does not clear.</p>
			<p class="reference--journal--first">El-&#173;Sanhouri AA, Foster RE, Petersen MR, et&#160;al. Ret&#173;i&#173;nal tears &#173;after posterior vitreous detachment and vitreous hemorrhage in patients on systemic anticoagulants. <span class="italic">Eye (Lond).</span> 2011;25(8):1016–1019.</p>
			<p class="reference--journal--mid">Sarrafizadeh R, Hassan TS, Ruby AJ, et&#160;al. Incidence of ret&#173;i&#173;nal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundus-&#173;obscuring vitreous hemorrhage. <span class="italic">Ophthalmology.</span> 2001;108(12):2273–2278.</p>
			<p class="reference--journal--last">Witmer MT, Cohen SM. Oral anticoagulation and the risk of vitreous hemorrhage and ret&#173;i&#173;nal tears in eyes with acute posterior vitreous detachment. <span class="italic">Ret&#173;i&#173;na.</span> 2013;33(3):621–626.</p>
			<p class="h2">Pigment Granules</p>
			<p class="body-text--no-indent-">In a patient without uveitis, retinitis pigmentosa, or a history of surgical or accidental eye trauma, the presence of pigmented cells in the anterior vitreous (“tobacco dust”), known as a <span class="italic">Shafer sign,</span> is highly suggestive of a ret&#173;i&#173;nal break (see <span class="xref-local">Chapter&#160;16</span>).</p>
			<p class="h2 ParaOverride-6">Cholesterolosis</p>
			<p class="body-text--no-indent-">Numerous yellow-&#173;white, gold, or multicolored cholesterol crystals are pres&#173;ent in the vitreous and anterior chamber in cholesterolosis, also known as <span class="italic">synchysis scintillans.</span> This condition appears almost exclusively in eyes that have under&#173;gone repeated or severe accidental or surgical trauma causing large intravitreal hemorrhages. The descriptive term synchysis scintillans refers to the highly refractile appearance of the cholesterol-&#173;containing crystals. In contrast to eyes with asteroid hyalosis, in which the opacities are evenly distributed throughout the vitreous cavity, eyes with cholesterolosis frequently have a PVD, which allows the crystals to &#173;settle inferiorly.</p>
			<p class="h2 ParaOverride-6">Amyloidosis</p>
			<p class="body-text--no-indent-">Bilateral vitreous opacification can occur as an early manifestation of the dominantly inherited form of familial amyloidosis, which is most commonly associated with a transthyretin mutation (<span class="xref-figure">Fig 17-13</span>). Amyloid infiltration of the vitreous is rare in nonfamilial cases. In addition to the vitreous, amyloid can be deposited in the ret&#173;i&#173;nal vasculature, the choroid, and the trabecular meshwork.</p>
			<p class="body-text">Ret&#173;i&#173;nal findings include hemorrhages, exudates, cotton-&#173;wool spots, and peripheral ret&#173;i&#173;nal neovascularization. In addition, infiltrations may be pres&#173;ent in the orbit, extraocular muscles, eyelids, conjunctiva, cornea, and iris. Nonocular manifestations of amyloidosis include upper-&#173; and lower-&#173;extremity polyneuropathy and central ner&#173;vous system abnormalities. Amyloid can be deposited in several organs, including the heart and skin, and in the gastrointestinal tract.</p>
			<p class="body-text">Initially, the extracellular vitreous opacities appear to lie adjacent to ret&#173;i&#173;nal vessels posteriorly; they &#173;later develop anteriorly. At first, the opacities appear granular and have wispy fringes, but as they enlarge and aggregate, the vitreous takes on a “glass-&#173;wool” appearance. With vitreous liquefaction or PVD, the opacities may be displaced into the visual axis, causing reduced vision and photophobia.</p>
			<p class="body-text">The differential diagnosis of amyloidosis includes chronic (dehemoglobinized) &#173;vitreous hemorrhage, lymphoma, sarcoidosis, and Whipple disease. Vitrectomy may be indicated for vitreous opacities when symptoms warrant intervention, but recurrent opacities may develop in residual vitreous. Histologic examination of removed vitreous shows material with a fibrillar appearance and a staining reaction characteristic of amyloid. Birefringence and electron microscopic studies are confirmatory. Immunocytochemical studies have shown the major amyloid constituent to be a protein resembling prealbumin.</p>
			<p class="reference--journal--single ParaOverride-5">Sandgren&#160;O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. <span class="italic">Surv Ophthalmol.</span> 1995;40(3):173–196.</p>
			</div>
			<p class="h1">Vitreous Abnormalities Secondary to Surgery</p>
			<div id="Chapt17_Top6">
			<p class="body-text--no-indent-">Incarceration of vitreous in the wound during cataract or vitreous surgery can lead to many postoperative complications. Following cataract surgery with vitreous incarceration, &#173;there is increased risk of infectious endophthalmitis, epithelial ingrowth, hypotony, shallow anterior chamber, peripheral anterior synechiae, and secondary glaucoma. Incarcerated vitreous in the wound and iridovitreal adhesions may cause chronic ocular discomfort with inflammation, cystoid macular edema, and optic nerve head edema (Irvine-&#173;Gass syndrome). &#173;These complications may be reduced by disconnecting any vitreous from anterior adhesions and incarcerations through vitrectomy.</p>
			<p class="body-text">Ret&#173;i&#173;nal detachment can be caused by contraction of vitreous incarcerated in cataract or vitrectomy incisions. Such detachments may be rhegmatogenous or tractional and may require treatment with vitrectomy and/or scleral buckling surgery (see <span class="xref-local">Chapter&#160;20</span>).</p>
			<p class="body-text">The risk of complications from vitreous loss during cataract surgery can be sharply reduced by careful anterior vitrectomy followed by meticulous closure of all wounds. For further discussion of the complications of cataract surgery and their management, see BCSC Section&#160;11, <span class="italic">Lens and Cataract.</span> For information about postoperative endophthalmitis, see BCSC Section&#160;9, <span class="italic">Intraocular Inflammation and Uveitis.</span></p>
			<p class="reference--journal--single">Harbour JW, Smiddy WE, Rubsamen PE, Murray TG, Davis JL, Flynn HW&#160;Jr. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. <span class="italic">Am J Ophthalmol.</span> 1995;120(3):302–307.</p>
		</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer013">
				<div id="_idContainer011" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/ICS00091.png" alt="" />
				</div>
				<div id="_idContainer012" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-1</span> A 3-dimensional rendering of spectral-domain optical coherence tomography (SD-OCT) imaging of vitreomacular traction (VMT) syndrome. The cone of vitreous is attached to and elevates the central fovea. <span class="figure-source-note">(Courtesy of Richard F. Spaide, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer016">
				<div id="_idContainer014" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/KIN00228.png" alt="" />
				</div>
				<div id="_idContainer015" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-2</span> Visualization of a thin layer of adherent vitreous during vitrectomy with the use of triamcinolone. This patient appeared to have a posterior vitreous detachment (PVD) and underwent a vitrectomy. <span class="figure-caption-bold">A,</span> A small amount of triamcinolone was injected into the vitreous cavity; the excess was aspirated from the surface of the retina, leaving a fine distribution of triamcinolone sticking to the adherent vitreous. <span class="figure-caption-bold">B,</span> The vitreous membrane was elevated using a diamond-dusted silicone scraper. Note that the vitreous is difficult to see; the sheet of triamcinolone is the clue to its presence. <span class="figure-caption-bold">C,</span> A wide-angle viewing system then was used to visualize the elevation of the adherent vitreous, and the vitrector was set to suction only. <span class="figure-caption-bold">D,</span>&#160;Note the extent of the adherent vitreous sheet, which was removed with the vitrector set to cut. <span class="figure-source-note">(Courtesy of Richard F. Spaide, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer019">
				<div id="_idContainer017" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-3</span> Epiretinal membrane (ERM). <span class="figure-caption-bold">A,</span> Scanning laser ophthalmoscope 30° fundus reflectance multicolor image reveals an ERM in the central macula with radiating striae of the internal limiting membrane (ILM) in the superior, temporal, and inferior macula. The colors in reflectance multicolor images are not exactly true to life. <span class="figure-caption-bold">B,</span> OCT scan through the fovea shows increased retinal thickening and cystoid edema with a large central cyst. The ERM is distorting the retinal surface temporally, which appears as several small optical voids between the ERM and the retina. <span class="figure-source-note">(Courtesy of Colin A. McCannel, MD.)</span></p>
				</div>
				<div id="_idContainer018" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/KIN00840.png" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer022">
				<div id="_idContainer020" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/AAX-10152.png" alt="" />
				</div>
				<div id="_idContainer021" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-4</span> SD-OCT line cube scan of the right macula of a 61-year-old woman with ERM. The visual acuity at the time of the scan was 20/30. A loss of foveal depression can be appreciated. The outer nuclear layer is thickened and peaks toward the retinal surface. The infrared reflectance image <span class="figure-caption-italic">(left)</span> shows the surface wrinkling with striae radiating outward from the central macula with the ERM. See also Activity 17-1. <span class="figure-source-note">(Courtesy of Colin A. McCannel, MD.) </span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer025">
				<div id="_idContainer023" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/AAX-10153.png" alt="" />
				</div>
				<div id="_idContainer024" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-5</span> ERM progression. SD-OCT image of a patient’s right macula with ERM that has developed over the previous 5 years. The ERM expanded and eventually covered the fovea with a secondary complete loss of foveal depression. In this patient, the ERM and retinal thickness did not change much after the fovea was covered. Visual acuity was initially 20/20, but declined slightly to 20/25 at the time the foveal contour was lost and has remained stable during follow-up. See also Activity 17-2. <span class="figure-source-note">(Courtesy of Colin A. McCannel, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer026" class="Basic-Text-Frame">
			<table id="table001" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="3">
							<p class="table-title"><span class="table-number">Table 17-1</span> The International Vitreomacular Traction Study Classification System <br />for Vitreomacular Adhesion, Traction, and Macular Hole</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Classification</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Subclassification</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Vitreomacular adhesion</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Size: focal (≤1500 µm) or broad (&gt;1500 µm)</p>
							<p class="table-body">Isolated or concurrent</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Vitreomacular traction (VMT)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Size: focal (≤1500 µm) or broad (&gt;1500 µm)</p>
							<p class="table-body">Isolated or concurrent</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Full-thickness macular hole</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Size: small (≤250 µm), medium (&gt;250–≤400 µm), or large (&gt;400 µm)</p>
							<p class="table-body">Status of vitreous: with or without VMT</p>
							<p class="table-body">Cause: primary or secondary</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-6" colspan="3">
							<p class="table-source-note">From Duker JS, Kaiser PK, Binder S, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. <span class="CharOverride-1">Ophthalmology.</span> 2013;120(12):2611–2619.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer027" class="_idGenObjectStyleOverride-1">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer030">
				<div id="_idContainer028" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/AAX-8304.png" alt="" />
				</div>
				<div id="_idContainer029" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-6</span> Vitreomacular traction syndrome. OCT scan of the macula through the fovea shows vitreomacular traction causing a large foveal cyst and distortion of the inner retina. An ERM is also present. <span class="figure-source-note">(Courtesy of Tara A. McCannel, MD, PhD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer033">
				<div id="_idContainer031" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/KIN00184.png" alt="" />
				</div>
				<div id="_idContainer032" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-7</span> Macular holes. <span class="figure-caption-bold">A,</span> Color fundus photograph of stage 1A hole with horizontal splitting of retinal layers and corresponding OCT scan showing stage 1A hole. <span class="figure-caption-bold">B,</span> Fundus photograph and corresponding OCT scan of stage 1B hole. <span class="figure-caption-bold">C,</span> Fundus photograph of stage 2 hole with small opening in inner layer eccentrically and corresponding OCT scan of stage 2 hole. <span class="figure-caption-bold">D,&#160;</span>OCT scan of stage 3 full-thickness hole with elevation of adjacent retinal edges. <span class="figure-caption-bold">E,</span> OCT scan of stage 4 full-thickness hole with operculum. <span class="figure-source-note">(Courtesy of Mark W. Johnson, MD, and Peter K. Kaiser, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer036">
				<div id="_idContainer034" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/AAX-10154.png" alt="" />
				</div>
				<div id="_idContainer035" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-8</span> SD-OCT line cube scan of the left macula of a 62-year-old woman who suffered loss of vision 18 months prior to presentation. At the time of the scan, the visual acuity of this eye was 20/40 (eccentric fixation). The infrared reflectance image (left) shows a hole in the central macular retina. See also Activity 17-3; scrolling through the images, a discontinuity of the retina in the central macular scans can be seen, corresponding to the macular hole. The scan through the macular hole (scan 10) shows an operculum. This operculum represents a small glial plug that helps keep the fovea together; when it is pulled away by the posterior vitreous, a macular hole is facilitated. Histologic studies indicate that the number of photoreceptors attached to the plug can vary, from none to many. The prominent posterior vitreous face can also be seen; its contour suggests that it is likely attached at the optic nerve head and peripheral macula (dome-shaped configuration), which is typical in idiopathic macular holes.<span class="figure-source-note"> (Courtesy of Colin A. McCannel, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer039">
				<div id="_idContainer037" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/AAX-0551.png" alt="" />
				</div>
				<div id="_idContainer038" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-9</span> Color fundus photograph of a prepapillary vascular loop. <span class="figure-source-note">(Courtesy of M. Gilbert Grand,&#160;MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer042">
				<div id="_idContainer040" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/AAX-0553.png" alt="" />
				</div>
				<div id="_idContainer041" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-10</span> Color fundus photograph shows extensive lattice degeneration and pigmentary change in a patient with Stickler syndrome. <span class="figure-source-note">(Courtesy of William F. Mieler, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer043" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/AAX-10155.png" alt="" />
			</div>
		</div>
		<div id="_idContainer044" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure 17-11</span> Familial exudative vitreoretinopathy (FEVR) with the <span class="figure-caption-italic">LRP5</span> mutation. <span class="figure-caption-bold">A–B,</span> The temporal retina shows a zone of nonperfusion that is horizontally V-shaped, causing a tractional macular fold. <span class="figure-caption-bold">C–D,</span> Fluorescein angiography images of the same patient demonstrate dragging of the vasculature. There is evidence of leakage and avascularity. <span class="figure-caption-bold">E, </span>Color fundus image montage from a patient with FEVR shows folding of the retina with massive exudation. <span class="figure-source-note">(Courtesy of Audina M. Berrocal, MD.)</span></p>
		</div>
		<div id="_idContainer045" class="Basic-Text-Frame">
			<table id="table002" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-10" />
					<col class="_idGenTableRowColumn-11" />
					<col class="_idGenTableRowColumn-12" />
					<col class="_idGenTableRowColumn-11" />
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-11" />
					<col class="_idGenTableRowColumn-14" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-15">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="7">
							<p class="table-title"><span class="table-number">Table 17-2</span> Genes That Cause Familial Exudative Vitreoretinopathy</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-7">
							<p class="table-column-head"><span class="CharOverride-2">Gene</span></p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-column-head"><span class="CharOverride-2">Disease(s)</span></p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-column-head"><span class="CharOverride-2">Chromosome</span></p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-column-head"><span class="CharOverride-2">Inheritance <br />Pattern</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body"><span class="CharOverride-1">EVR1</span> (<span class="CharOverride-1">FZD4,</span> 11q14.2)</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Exudative vitreoretinopathy</p>
							<p class="table-body">Retinopathy of prematurity</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">11</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">AD</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-8">
							<p class="table-body"><span class="CharOverride-1">EVR2</span> (<span class="CharOverride-1">NDP,</span> Xp11.3)</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">Exudative vitreoretinopathy</p>
							<p class="table-body">Norrie disease</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">X</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">X-linked</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table CellOverride-8">
							<p class="table-body"><span class="CharOverride-1">EVR3</span> (11p13–p12)</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">Exudative vitreoretinopathy</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">11</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">AD</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body"><span class="CharOverride-1">EVR4</span> (<span class="CharOverride-1">LRP5,</span> 11q13.2)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Exudative vitreoretinopathy</p>
							<p class="table-body">Endosteal hyperostosis</p>
							<p class="table-body">Osteopetrosis (AD)</p>
							<p class="table-body">Osteoporosis-pseudoglioma syndrome</p>
							<p class="table-body">Osteosclerosis</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">11</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">AD, AR</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-1">EVR5</span> (<span class="CharOverride-1">TSPAN12,</span> 7q31.31)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Exudative vitreoretinopathy</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">7</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">AD</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-6" colspan="7">
							<p class="table-source-note">AD = autosomal dominant; AR = autosomal recessive.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer048">
				<div id="_idContainer046" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/ICS00089.png" alt="" />
				</div>
				<div id="_idContainer047" class="Basic-Text-Frame">
					<p class="figure-caption ParaOverride-12"><span class="figure-number">Figure 17-12</span> Color fundus photograph of asteroid hyalosis. <span class="figure-source-note">(Courtesy of Hermann D. Schubert, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer051">
				<div id="_idContainer049" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="OPERATOR_BCSC1819_S12_C17_p331-350_3P-web-resources/image/KIN00229.png" alt="" />
				</div>
				<div id="_idContainer050" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 17-13</span> Amyloidosis. Images from a 57-year-old woman with a history of vitrectomy for floaters in the right eye. A cataract subsequently developed in the right eye and was extracted. Her vision then decreased in the left eye, which she ascribed to a cataract. <span class="figure-caption-bold">A,</span> Color fundus photograph of the left eye showed a dense vitreous infiltration; there was no cataract, and intraocular pressure was markedly elevated. Review of systems revealed carpal tunnel syndrome in both wrists. <span class="figure-caption-bold">B,</span> After vitrectomy surgery on the left eye, the color fundus photograph revealed retinal hemorrhages along the inferotemporal vascular arcade. <span class="figure-caption-bold">C,</span> The removed vitreous material, stained with Congo red, demonstrated birefringence <span class="figure-caption-bold">(D)</span>. The patient was found to have a mutation affecting transthyretin. Glaucoma commonly develops in patients with transthyretin-related familial amyloidotic polyneuropathy. <span class="figure-source-note">(Courtesy of Richard F. Spaide, MD.)</span></p>
				</div>
			</div>
		</div>
	</body>
</html>
